🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry

Recruitingn/aAges 18 Years - 120 YearsAllChina National Center for Cardiovascular Diseases
NCT05598632 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is aimed to validate the existing stroke risk stratification model for patients with atrial fibrillation (AF) (CHA2DS2-VASc Score, CHADS2 Score, ATRIA score, ABC score, etc.) and establish a new stroke risk assessment model using a nationwide AF -specific registry in China.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * 18 years of age or older; male or female. * History of documented atrial fibrillation. * Able to provide written informed consent. Exclusion Criteria: * Subjects with moderate or severe mitral stenosis or a mechanical heart valve * Subjects with previous or planned AF ablation. * Subjects with previous or planned left atrial appendage closure. * Subjects unable to cooperate with follow-up after assessment.
💊

What it tests

  • Not listed
📍

Where

1 site
Fuwai Hospital, CAMS & PUMC
Beijing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy